Valuation: OrthoPediatrics Corp.

Market Cap 512M 448M 411M 383M 727M 48.78B 739M 4.95B 1.92B 23.93B 1.92B 1.88B 82.45B P/E 2026 *
-17.1x
P/E 2027 * -24.9x
Enterprise Value 512M 448M 411M 383M 727M 48.78B 739M 4.95B 1.92B 23.93B 1.92B 1.88B 82.45B EV / Sales 2026 *
1.93x
EV / Sales 2027 * 1.73x
Free-Float
67.15%
Yield 2026 *
-
Yield 2027 * -
1 day+3.37%
1 week+1.68%
Current month+4.29%
1 month+18.68%
3 months+24.22%
6 months+13.61%
Current year+12.33%
1 week 18.45
Extreme 18.45
20.75
1 month 17.13
Extreme 17.13
20.75
Current year 14.42
Extreme 14.42
20.75
1 year 14.42
Extreme 14.42
23.7
3 years 14.42
Extreme 14.42
45.96
5 years 14.42
Extreme 14.42
73.91
10 years 14
Extreme 14.0001
73.91
Manager TitleAgeSince
Chief Executive Officer 47 02/06/2021
Director of Finance/CFO 58 31/01/2015
Chief Tech/Sci/R&D Officer - 31/12/2021
Director TitleAgeSince
Director/Board Member 47 02/11/2021
Chairman 75 02/06/2021
Director/Board Member 70 31/12/2010
Date Insider Type Main position Quantity % Market Cap.
06-08Free

Director

11,436 0.0445%
06-08Free

Director

11,436 0.0445%
06-08Free

Chairman

11,436 0.0445%
Change 5-day change 1-year change 3-year change Capi.($)
+3.37%+1.68%-9.89%-54.50% 512M
+0.13%+3.30%-16.66%+7.03% 125B
+0.22%-0.66%+2.17%-5.36% 12.77B
+7.83%+4.05%+43.14%+108.31% 8.71B
-0.64%+0.71%-47.91%-71.81% 3.98B
+1.85%+3.66%+21.34%+40.15% 2.62B
-1.23%+9.52%-10.95%-14.48% 1.84B
-0.41%+2.18%-4.28%-25.04% 1.61B
-3.31%-9.68%+216.61%+153.84% 1.54B
Average +1.32%+4.51%+21.51%+15.35% 17.64B
Weighted average by Cap. +3.73%+3.16%-9.55%+10.81%

Financials

2026 *2027 *
Net sales 265M 232M 213M 198M 376M 25.24B 382M 2.56B 992M 12.38B 995M 974M 42.65B 297M 259M 238M 222M 421M 28.23B 428M 2.86B 1.11B 13.85B 1.11B 1.09B 47.71B
Net income -26.4M -23.07M -21.19M -19.76M -37.46M -2.51B -38.09M -255M -98.86M -1.23B -99.14M -96.99M -4.25B -17.65M -15.43M -14.17M -13.21M -25.04M -1.68B -25.47M -171M -66.1M -824M -66.29M -64.85M -2.84B
Net Debt - -
Logo OrthoPediatrics Corp.
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
Employees
602
Date Price Change Volume
02/07/26 US$19.95 +3.37% 122,304
01/07/26 US$19.30 +0.89% 163,150
30/06/26 US$19.13 -4.73% 242,928
29/06/26 US$20.08 -1.08% 183,123
26/06/26 US$20.30 +3.47% 542,417
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
19.95USD
Average target price
24.67USD
Spread / Average Target
+23.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KIDS Stock